The Business Times
SUBSCRIBERS

In Brief

google-preferred-sourceAdd BT as a preferred source
Published Tue, Jan 6, 2015 · 09:50 PM

QT Vascular clinical trial exceeds patient enrolment goal

QT VASCULAR said that the clinical trial for its Chocolate® Touch drug-coated balloon in Europe and New Zealand has "substantially exceeded" its patient enrolment goal for Q4 2014. The company expects to obtain CE marking regulatory approval for the product in the second half of 2015, which would allow it to market the product in the European Union.

BBB+ rating for AG Trust's golf course holding company

QT VascularAccordia Golf TrustSakae Holdings

Copyright SPH Media. All rights reserved.

Reuse this contentFeedback
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More